Skip to main content
Featured products
Balloon dilatation catheter for percutaneous transluminal valvuloplasty, ideal for TAVI…
Temporary myocardial pacing cables intended for use after cardiac surgery. Available in multiple…
OSYPKA PACE 101H® is a single-chamber external pacemaker ideal for temporary cardiac pacing in…
Wide range of anterograde and retrograde cardioplegia cannulas, cardiac suctions, and perfusion…
The OSYPKA PACE 300® is a three-chamber external pacemaker designed for temporary biventricular…
CoraSim® is a heart simulator designed for training and education in cardiac electrophysiology…
The ICONCore® is a portable, non-invasive cardiometer that enables continuous measurement of…

    Extender paclitaxel-eluting PTA balloon

    A drug-eluting balloon (DCB) with paclitaxel for angioplasty in peripheral arterial disease above the knee.

    Extender paclitaxel-eluting PTA balloon

    A drug-eluting balloon (DCB) with paclitaxel for angioplasty in peripheral arterial disease above the knee.


    The Extender paclitaxel-eluting PTA balloon is a paclitaxel-coated balloon dilatation catheter, specially designed for percutaneous transluminal angioplasty (PTA) in the treatment of peripheral arterial disease (PAD).

    Optimized for supra-patellar peripheral interventions, the Extender paclitaxel-eluting PTA balloon combines mechanical efficacy with precise drug delivery. Its advanced coating allows for controlled administration of paclitaxel, a potent anti-restenotic agent, during brief inflations, reducing drug loss and maximizing its therapeutic efficacy.

    With a technology that improves drug retention at the lesion site, Extender offers a minimally invasive alternative to prevent restenosis after PTA procedures.

    Features

    • Paclitaxel-coated balloon to inhibit restenosis.
    • Designed for above-the-knee interventions.
    • Brief inflation with effective drug release.
    • Optimised coating for minimal drug loss.
    • High-performance and precise PTA catheter.

    Benefits

    • Significantly reduces restenosis in peripheral arteries.
    • Minimises patient exposure to repeated procedures.
    • Improves long-term vessel patency.
    • Rapid paclitaxel administration during inflation.
    • Optimises clinical outcomes in PAD patients.